Association between the NBS1 Glu185Gln polymorphism and lung cancer risk: A systemic review and meta-analysis

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2711-2715

  Wang, Lixin ^a   Cheng, Jinsong ^a   Gao, Jinyu ^a   Wang, Jipeng ^a   Liu, Xiaoning ^a   Xiong, Liwen ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Lung cancer; Meta analysis; NBS1; Polymorphism

Indexed keywords

NIBRIN;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; NBS1 GENE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK;

EID: 84878397619     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2358-5     Document Type: Article

References (39)

1. Herbst RS, Heymach JV, Lippman SM (2008) Lung cancer. N Engl J Med 359:1367-1380
2. El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012) Some epidemiological measures of cancer in kuwait: national cancer registry data from 2000-2009. Asian Pac J Cancer Prev 13:3113-3118
3. De Ruysscher D, Faivre-Finn C, Nestle U et al (2010) European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 28:5301-5310
4. Fidias P, Novello S (2010) Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol 28:5116-5123
5. Goldstraw P, Ball D, Jett JR et al (2011) Non-small-cell lung cancer. Lancet 378:1727-1740
6. Pennathur A, Luketich JD (2009) Multimodal treatment with surgical resection for stage IIIB non-small-cell lung cancer. Lancet Oncol 10:742-743
7. van Meerbeeck JP, Fennell DA, De Ruysscher DK (2011) Small-cell lung cancer. Lancet 378:1741-1755
8. Brennan P, Hainaut P, Boffetta P (2011) Genetics of lung-cancer susceptibility. Lancet Oncol 12:399-408
9. Dong LM, Potter JD, White E et al (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299:2423-2436
10. Tseng SF, Chang CY, Wu KJ et al (2005) Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem 280:39594-39600
11. Falck J, Forment JV, Coates J et al (2012) CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination. EMBO Rep 13:561-568
12. Yanagihara H, Kobayashi J, Tateishi S et al (2011) NBS1 recruits RAD18 via a RAD6-like domain and regulates Pol eta-dependent translesion DNA synthesis. Mol Cell 43:788-797
13. Foster SS, De S, Johnson LK et al (2012) Cell cycle- and DNA repair pathway-specific effects of apoptosis on tumor suppression. Proc Natl Acad Sci USA 109:9953-9958
14. Wu J, Zhang X, Zhang L et al (2012) Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell 46:351-361
15. Hebbring SJ, Fredriksson H, White KA et al (2006) Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 15:935-938
16. Lu M, Lu J, Yang X et al (2009) Association between the NBS1 E185Q polymorphism and cancer risk: a meta-analysis. BMC Cancer 9:124
17. Park SL, Bastani D, Goldstein BY et al (2010) Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis 31:1264-1271
18. Zhao JW, Ling XX, Yang L et al (2011) Association of polymorphism 8360G>C in NBS1 gene and the risk of lung cancer in southern Chinese population. Acad J Guangzhou Med Coll 39:5-8
19. Zienolddiny S, Campa D, Lind H et al (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27:560-567
20. Lan Q, Shen M, Berndt SI et al (2005) Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 49:317-323
21. Ryk C, Kumar R, Thirumaran RK et al (2006) Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 54:285-292
22. Fan LH, Chen JL, Cai L (2010) Study on the association between DNA double-strand break repair gene NBS1 polymorphisms and susceptibility on lung cancer. Zhonghua Liu Xing Bing Xue Za Zhi 31:213-217
23. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557-560
24. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
25. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
26. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
27. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
28. Liang G, Lin DX (2004) Polymorphisms in DNA repair genes and susceptibility to lung cancer. Chinese Peking Union Medical University Doctoral Dissertation 2004
29. Wang Z, Cui D, Lu W (2010) NBS1 8360G>C polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 123:557-561
30. Hou YY, Toh MT, Wang X (2012) NBS1 deficiency promotes genome instability by affecting DNA damage signaling pathway and impairing telomere integrity. Cell Biochem Funct 30:233-242
31. Xu JL, Hu LM, Huang MD et al (2012) Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese. Asian Pac J Cancer Prev 13:851-856
32. Hsu DS, Chang SY, Liu CJ et al (2010) Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity. Cancer Sci 101:1029-1037
33. Ehlers JP, Harbour JW (2005) NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 11:1849-1853
34. Yang MH, Chiang WC, Chou TY et al (2006) Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res 12:507-515
35. Gao J, Zhang H, Arbman G et al (2008) RAD50/MRE11/NBS1 proteins in relation to tumour development and prognosis in patients with microsatellite stable colorectal cancer. Histol Histopathol 23:1495-1502
36. Subramanian J, Simon R (2010) Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst 102:464-474
37. Cheng Z, Wang W, Song YN et al (2012) hOGG1, p53 genes, and smoking interactions are associated with the development of lung cancer. Asian Pac J Cancer Prev 13:1803-1808
38. Peng WJ, He Q, Yang JX et al (2012) Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk. Mol Biol Rep 39:5187-5194
39. Zhang Y, Chen GQ, Ji Y et al (2012) Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma. Mol Biol Rep 39:6203-6211